CLINICAL_TRIALS
trial_result
· 2020-07-22
Clinical Trial Update: Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy [Phase 2]
Summary
Phase 2 safety study of eteplirsen in early-stage Duchenne Muscular Dystrophy completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sarepta Therapeutics, Inc. | Conditions: Duchenne Muscular Dystrophy (DMD) | Phase 2 | Status: COMPLETED | Results posted: 2020-07-22